| Document Date: 2014-11-25 14:31:59
Open Document File Size: 167,61 KBShare Result on Facebook
City MONTREAL / New York / Paris / / Company Sanofi Canada / Anaphylaxis Canada / IMS Health / Association / Genzyme / / Country Canada / / Currency USD / / / Event Company Listing Change / / Facility Hospital Purchases / / IndustryTerm pharmaceutical product / pharmaceuticals / food allergies / therapeutic solutions / consumer healthcare / over-the-counter products / healthcare / diabetes solutions / / MedicalCondition allergies / anaphylaxis / diabetes / Allergy / food allergies / severe allergies / / MedicalTreatment emergency treatment / / Organization Allergy Asthma Information Association / Sanofi Canada’s Consumer Unit / Association québécoise / / Person Susan Waserman / Joey Gill / Tristan / Jennifer Roberge / Tracey Ramsay / Niki Kerimova / Robert Stephens / / / Position Vice President / global healthcare leader / / Product epinephrine / / Technology SAN / therapeutic solutions / / URL www.allerject.ca / www.youtube.com/user/AllerjectCA / /
SocialTag |
Allerject™ – now we’re talking! Canadians at risk of anaphylaxis and those who care for them are choosing Allerject™ as their emergency treatment option FOR IMMEDIATE RELEASE MONTREAL (June 16, 2014) Allerject™